Join
Live feed
·
PRReleasevia Quantisnow
CalciMedica Inc. logo

CalciMedica Announces FDA Alignment on Phase 2b Trial Design for Auxora in Acute Pancreatitis and Identifies Disease's First Potential Registrational Endpoints

ByQuantisnow·Wall Street's wire, on your screen.
CALC· CalciMedica Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CALC (CalciMedica Inc.) and more on Quantisnow.